After CO2 and Hydrocarbon: Where Cannabis Extraction Goes Next

August 20, 2026

Photo by This_is_Engineering via Pixabay.

Walk into almost any licensed extraction facility built between 2015 and 2020 and you'll find some version of the same two machines: a closed-loop hydrocarbon system running butane or propane, or a supercritical CO2 rig humming away at pressures north of 1,000 psi. That's not a coincidence. Those two chemistries won the first decade of legal cannabis processing because they were the ones regulators could understand, insurers could underwrite, and manufacturers could scale without reinventing the wheel every quarter. A decade later, the chemistry itself hasn't moved much. No new solvent class has emerged in trade coverage or patent filings that looks poised to unseat butane or CO2 on cost, safety, or yield.

That doesn't mean extraction has stalled -- it means the interesting fight moved downstream of the solvent question entirely. On one side, consumers are voting with their dollars for products that skip solvents altogether: ice-water hash, fresh-press rosin, and the vape cartridges built from them. On the other, the operators still running hydrocarbon and CO2 lines are quietly rebuilding those same rigs around sensors, software, and automated process control, chasing consistency and margin the way food and pharma manufacturers did once their own core chemistries matured. Neither trend requires a breakthrough molecule. Both are reshaping what a competitive processing floor looks like heading into 2026 and 2027. The question this piece actually answers isn't which solvent comes next -- it's what "next-gen extraction" concretely looks like on a factory floor when the solvent question is basically settled.

Why CO2 and Hydrocarbon Hit a Ceiling

Photo by This_is_Engineering via Pixabay.

CO2 and hydrocarbon extraction didn't win because they were elegant -- they won because they were legible to the systems built around them. Supercritical and subcritical CO2 extraction let processors tune pressure and temperature to selectively pull cannabinoids and terpenes without leaving flammable solvent behind, which made it an easy sell to regulators nervous about the extraction-lab fires that made headlines in the early 2010s. Hydrocarbon extraction using butane or propane came with more explosion risk, but it delivered higher yields and full-spectrum, terpene-rich concentrates that dabbers wanted -- and once closed-loop systems and fire-code standards matured, most jurisdictions were willing to license it. By the mid-2010s, these two methods had essentially split the market: CO2 for vape distillate and tinctures where purity and shelf stability mattered most, hydrocarbon for live resin, budder, and sauce where flavor and potency were the selling point.

What's notable now is how little has changed on the chemistry side since then. A scan of current trade press and industry patent activity doesn't turn up a credible third solvent chemistry waiting in the wings -- no exotic supercritical fluid, no novel hydrocarbon blend, nothing that outperforms the incumbents enough to justify the capital and regulatory lift of switching. That's a normal endpoint for an industrial process: methanol and ethyl acetate haven't been meaningfully displaced in pharmaceutical solvent extraction in decades either, because once a chemistry clears the safety and yield bar, the incentive to replace it drops fast.

The real pressure on CO2 and hydrocarbon isn't technical -- it's perceptual and financial. Residual solvent testing requirements exist precisely because trace butane or propane can linger in a poorly purged product, and even when a batch passes every compliance threshold, plenty of consumers still hear butane hash oil and think of a chemical process rather than a plant extract. At the same time, both extraction methods have commoditized. The equipment is well-documented, the technique is teachable, and margins on standard distillate and BHO have compressed as more licensed processors entered the market with functionally identical setups. Put those two pressures together -- stigma on one end, thinning margins on the other -- and you get the setup for the two real movements happening now: a consumer pull toward skipping solvents entirely, and a producer push toward wringing more consistency and efficiency out of the rigs already on the floor.

Solventless Goes Mainstream: The Rosin Numbers

Photo by Jess Loiterton via Pexels.

Rosin used to be the extraction method for people who didn't trust extraction methods -- a heat-and-pressure squeeze of flower or ice-water hash that traded yield for purity and bragging rights among dab connoisseurs. That framing hasn't held up well against the sales data. In mature, well-tracked markets like California and Colorado, rosin's share of dabbable concentrate dollar sales has climbed past 20%, a meaningful jump from the low single digits it occupied just a few years into legalization. That's not a rounding error; it's a category moving from artisanal niche toward mainstream shelf staple, at a moment when overall concentrate sales growth in a lot of markets has flattened.

The bigger structural shift is that solventless has stopped being confined to dabbable concentrates altogether. Rosin vape cartridges have grown noticeably as a format over the past couple of years, and that matters because vapes are the highest-volume, most habitual concentrate format in most legal markets. Putting solventless rosin into a cartridge format puts it in direct competition with distillate and live resin carts -- categories that have dominated vape shelves largely because they were easier and cheaper to manufacture at volume. If rosin carts keep gaining share, it's a sign the solventless argument is winning with everyday cartridge buyers, not just dab-rig purists.

The infrastructure has kept pace with the demand. Commercial rosin presses, bubble hash washing systems, ice-water extraction machines, and pneumatic presses built specifically to preserve terpene profiles and minor cannabinoids are now standard equipment lines from extraction manufacturers, not custom-built shop projects. Brands are leaning into this directly. Speaking at MJBizCon 2025, Sun Theory VP Mitch Barton said the company's Dialed in Gummies line -- sold across Arizona, Colorado, Massachusetts, and Ohio -- sources solventless rosin over distillate or live resin specifically because it retains minor terpenes, sesquiterpenes, minor cannabinoids, and THC that other extraction methods strip away in processing.

That's a claim worth taking seriously on mechanism, not just marketing. Distillation involves prolonged heat exposure that volatilizes and degrades the more delicate terpenes and minor cannabinoids; hydrocarbon extraction requires a purge step that can also cook off some of that same volatile profile. Ice-water hash and fresh-press rosin skip both the chemical solvent and, in rosin's case, most of the heat exposure, which is the whole basis of the entourage-effect argument for why solventless products taste and hit differently. That's a real chemical rationale, even if the clinical evidence on entourage effects in humans is still thin.

The Business Case: Solventless at Commercial Scale

Photo by Vitaly Gariev via Pexels.

The knock on solventless has always been scale. Ice-water hash and rosin pressing are mechanically simple, but simple doesn't mean fast -- washing, drying, and pressing trichomes by hand or with small-batch equipment is labor-intensive in a way that a hydrocarbon closed-loop system running overnight batches just isn't. That's starting to change on the equipment side. In spring 2026, High Tide Industries partnered with T0SCO to deploy proprietary solventless extraction technology at commercial scale, with initial production runs targeted for early Q2 2026 and commercial product availability slated for Q3 2026. High Tide CEO Bernard Gruberg framed the move plainly: the goal is to answer brand demand to go solventless without sacrificing scale or margins.

That framing is the whole ballgame. Plenty of processors can make excellent small-batch rosin; almost none have proven they can hit the throughput and potency consistency that a multi-state brand needs to keep shelves stocked without reverting to solvent-based shortcuts when demand spikes. The real test for this next phase of solventless isn't whether the product tastes better -- reviewers and dabbers have largely settled that question in rosin's favor -- it's whether a facility can run it like an industrial process: predictable yield per input, consistent potency batch to batch, and a cost structure that doesn't require premium pricing to stay profitable.

There's a physical ceiling here worth being honest about. Solventless yields are inherently capped by how much resin content is actually present in the starting material and by the mechanical efficiency of separating it -- you're not chemically pulling cannabinoids off plant matter the way CO2 or hydrocarbon does, you're mechanically separating what's already there. That means even a perfectly automated ice-water wash or rosin press is working with a lower theoretical yield ceiling than solvent-based extraction on the same input material. Practically, that suggests per-gram production costs for solventless are likely to stay structurally higher than for distillate or standard BHO, even after automation shaves down labor costs.

The reasonable read on High Tide's bet, and others like it, is that automation can close the gap between artisanal and commercial-scale solventless production without closing it entirely. Whether that's enough to push solventless rosin into true value-tier pricing, or whether it settles into a well-defended premium category with better margins than mass-market flower but real ceilings on volume, is genuinely unresolved -- and it's the kind of question that will get answered by 2027 sales data, not by product launch press releases.

Automation, AI, and the 'Industry 4.0' Layer

In 2026, an estimated 56% of extraction facilities have adopted automation and advanced monitoring technologies, outpacing the 45% that have implemented energy-efficient systems, highlighting a growing industry focus on process optimization over sustainability upgrades.

If you can't change the chemistry, you change what surrounds it -- and that's exactly what's happening on hydrocarbon and CO2 lines that aren't going anywhere. Market analysis pointing toward the next three to five years in extraction doesn't describe a new solvent; it describes fully integrated, AI-enabled processing ecosystems built around sustainability, safety, and product personalization layered onto rigs that are, chemically, the same ones running today. The pitch from equipment vendors has shifted accordingly, from selling a single-purpose extraction machine to selling a modular, software-controlled system where components are swappable and interoperable rather than locked into one configuration.

Concretely, that means IoT sensors tracking temperature, pressure, and solvent ratios in real time instead of relying on operator logs; blockchain-based batch tracking that ties a finished product back to specific extraction run parameters for compliance and recall purposes; and cloud computing tying that data together for seed-to-sale traceability that regulators in most legal states already require in some form. None of this changes what's happening inside the extraction vessel. It changes how tightly that process can be controlled, monitored, and replicated across shifts, facilities, and even states for multi-state operators trying to keep potency and terpene profiles consistent across markets with different testing regimes.

Sector estimates suggest roughly 55% to 58% of extraction facilities were adopting automation or advanced monitoring systems by 2026, with around 45% moving toward energy-efficient systems specifically. Those numbers are worth flagging clearly: they come from industry market reports of uncertain methodological rigor, not peer-reviewed research or government survey data, so they should be read as a directional signal that automation adoption is genuinely widespread -- not as a precise measurement anyone should cite to two significant figures.

The pattern underneath those numbers is a familiar one from other manufacturing sectors. Food processing and pharmaceutical manufacturing both went through a phase where the core chemistry -- pasteurization, tableting, fermentation -- matured and commoditized, and competitive advantage shifted almost entirely to process control: consistency, contamination prevention, batch documentation, and yield optimization through data rather than through changing the underlying reaction. Cannabis extraction looks to be hitting that same inflection point roughly a decade after the core solvent methods locked in, which tracks reasonably well against how long it took similar maturation cycles to play out in those other industries.

Regulation Is Quietly Picking Winners

Photo by RDNE Stock project via Pexels.

Regulators rarely set out to pick a winning technology, but compliance costs have a way of doing it for them anyway. Global regulatory trends are increasingly favoring extraction methods framed as safer and more environmentally sustainable, which happens to line up neatly with where consumer demand is already headed -- toward solventless products marketed on exactly those terms. Whether that's cause or effect is genuinely unclear, but the two forces are reinforcing each other.

What's measurable is the cost side. Hydrocarbon and CO2 operations carry an accumulating compliance burden: closed-loop system certification, fire-code requirements specific to flammable-solvent handling, and third-party lab testing for residual solvents that gets more rigorous, not less, as state programs mature. Each of those requirements raises the capital and operating cost of running a compliant hydrocarbon or CO2 line, which raises the effective barrier to entry for smaller operators and squeezes anyone running outside full compliance out of the licensed market entirely.

There's a real historical parallel here, and it's worth naming directly: 20th-century food and pharmaceutical manufacturing went through the same consolidation once Good Manufacturing Practice-style compliance costs made small, undercapitalized operators economically unviable. The technology itself -- pasteurization, tablet pressing -- wasn't the moat. The ability to document, certify, and consistently meet a rising compliance bar was. Reasoning from that precedent, the extrapolation for cannabis extraction is that market leadership consolidates among processors who are both technologically advanced and well-capitalized enough to absorb rising compliance costs, while smaller solventless-focused artisans either get acquired by those larger players or carve out a defended craft-premium niche the way small-batch cheese and artisanal spirits producers have in food and beverage.

That's a reasoned bet, not a certainty, and there's a real counter-case. Heavy-handed regulation could just as easily entrench the hydrocarbon and CO2 operators who already sank capital into compliant closed-loop systems years ago, precisely because ripping out that infrastructure to retool for solventless production is its own significant capital expense. An operator with a fully depreciated, fully compliant hydrocarbon line has less incentive to abandon it than a new entrant has to build solventless from scratch -- which means regulatory pressure could reinforce incumbency on either side of the solventless divide, depending on which operators are already sitting on which sunk costs when the next round of compliance requirements lands.

None of this hinges on a lab somewhere discovering a better solvent. The post-CO2/hydrocarbon era is being defined by two forces that have nothing to do with the extraction vessel's chemistry: consumers increasingly rewarding minimally processed, solventless products they associate with better flavor and a fuller cannabinoid profile, and manufacturers digitizing the same hydrocarbon and CO2 processes they've been running for a decade rather than replacing them. Both trends are real, both are measurable in current sales data and vendor activity, and neither required anyone to invent a new molecule.

What's genuinely unresolved is whether solventless can clear its own mechanical ceiling. Yield, labor intensity, and throughput are physical constraints tied to how much resin is actually in the starting material and how efficiently it can be mechanically separated -- automation and better equipment can chip away at labor cost and consistency, but they can't manufacture trichome content that isn't there. Whether deployments like High Tide's T0SCO partnership prove that solventless can hit real commercial scale without losing its quality edge, or whether it settles into a permanent premium tier with a hard volume ceiling, is a question the next two to three years of production data will answer -- not something worth declaring settled from a launch announcement.

The more durable takeaway is about where the business opportunity actually sits. The processors and equipment vendors most likely to come out ahead aren't necessarily the ones chasing the next exotic extraction chemistry -- that well looks fairly dry right now. They're the ones treating extraction as a data and process-control problem: investing in sensors, batch tracking, and modular equipment that can flex between product lines as demand shifts, the same way food and pharma manufacturers built their moats once their core chemistries matured. For mid-size processors and equipment makers willing to retool around that logic now, rather than waiting for certainty, that's a real window -- and windows like this tend to close once the larger, better-capitalized players finish consolidating around exactly the same insight.